Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL.

Human mutation - 1 Jun 2006

Lucchiari S, Pagliarani S, Salani S, Filocamo M, Di Rocco M, Melis D, Rodolico C, Musumeci O, Toscano A, Bresolin N, Comi G P

Abstract excerpt

Glycogenosis type III (Cori disease) is an autosomal recessive disorder caused by the deficiency of the glycogen debranching enzyme, encoded by the AGL gene, and existing in six isoforms alternately spliced in a tissue-specific way. Generally, disease onset occurs early on starting from the first year of life, with hepatomegaly, hypoglycemia, hyperlipidemia, increased CK levels, and, in some cases, short stature...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Codon, Nonsense
Share to Frameshift Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycogen Debranching Enzyme System

Share to Hepatomegaly

Share to Muscular Diseases

Share to Mutation, Missense

Share to Sequence Alignment

Source

Identifiers

PMID: 16705713
DOI: 10.1002/humu.9426

Genes

AGL

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatic and neuromuscular forms of glycogenosis type III: nine mutations in AGL.PMID 16705713Read ↗

Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3.Semantic proximity Read ↗

Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.Semantic proximity Read ↗

Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area.Semantic proximity Read ↗

Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.Semantic proximity Read ↗

Glycogen storage disease type III in the Irish population.Semantic proximity Read ↗

Molecular and clinical delineation of 12 patients with glycogen storage disease type III in Western Turkey.Semantic proximity Read ↗

Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.Semantic proximity Read ↗

Mutational analysis of the AGL gene: five novel mutations in GSD III patients.Semantic proximity Read ↗

Clinicopathological analysis of the homozygous p.W1327X AGL mutation in glycogen storage disease type 3.Semantic proximity Read ↗

Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL.Semantic proximity Read ↗

A founder splice site mutation underlies glycogen storage disease type 3 in consanguineous Saudi families.Semantic proximity Read ↗

A Rare Case of Glycogen Storage Disease Type IIIa with a Novel Homozygous AGL Splice Variant in a Two-Year-Old Female born out of Consanguineous MarriageSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.